NeuroPace, Inc.
US ˙ NasdaqGM ˙ US6412881053

SecurityNPCE / NeuroPace, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership68,555 shares
Latest Disclosed Value $ 1,058,490
Barclays Plc reports 5.48% increase in ownership of NPCE / NeuroPace, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 68,555 shares of NeuroPace, Inc. (US:NPCE) valued at $1,058,489 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 64,995 shares of NeuroPace, Inc.. This represents a change in shares of 5.48% during the quarter. The current value of the position is $1,088,653 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F NEUROPACE COM 641288105 68,555 3,560 5.48 1,058 57.91 0.0003
2026-03-31 2025-09-30 13F/A-3 NEUROPACE COM 641288105 64,995 -6,677 -9.32 670 -16.04 0.0001
2026-03-19 2025-09-30 13F/A-2 NEUROPACE COM 641288105 20,633 -51,039 144 0.0000
2025-11-12 2025-09-30 13F NEUROPACE COM 641288105 64,995 -6,677 670 0.0001
2026-02-27 2025-06-30 13F/A-2 NEUROPACE COM 641288105 71,672 40,508 129.98 798 108.36 0.0002
2025-08-14 2025-06-30 13F/A-1 NEUROPACE COM 641288105 71,672 40,508 1 0.0002
2025-08-13 2025-06-30 13F NEUROPACE COM 641288105 71,672 40,508 1 0.0001
2026-03-17 2025-03-31 13F/A-1 NEUROPACE COM 641288105 31,164 3,555 12.88 383 24.35 0.0001
2025-05-15 2025-03-31 13F NEUROPACE COM 641288105 31,164 3,555 0 0.0001
2026-03-19 2024-12-31 13F/A-1 NEUROPACE COM 641288105 27,609 6,976 33.81 309 115.38 0.0001
2025-02-13 2024-12-31 13F NEUROPACE COM 641288105 27,609 6,976 0 0.0001
2026-03-31 2024-09-30 13F/A-2 NEUROPACE COM 641288105 20,633 16,007 346.02 144 320.59 0.0000
2024-11-19 2024-09-30 13F/A-1 NEUROPACE COM 641288105 20,633 16,007 0 0.0000
2024-11-15 2024-09-30 13F NEUROPACE COM 641288105 20,633 16,007 0 0.0000
2026-03-23 2024-06-30 13F/A-1 NEUROPACE COM 641288105 4,626 -9,244 -66.65 35 -81.42 0.0000
2024-08-14 2024-06-30 13F NEUROPACE COM 641288105 4,626 -9,244 0 0.0000
2026-03-24 2024-03-31 13F/A-1 NEUROPACE COM 641288105 13,870 -101 -0.72 183 27.08 0.0001
2024-05-15 2024-03-31 13F NEUROPACE COM 641288105 13,870 -101 0 0.0001
2026-03-25 2023-12-31 13F/A-1 NEUROPACE COM 641288105 13,971 3,132 28.90 144 37.14 0.0001
2024-02-15 2023-12-31 13F NEUROPACE COM 641288105 13,971 3,132 0 0.0001
2026-03-26 2023-09-30 13F/A-1 NEUROPACE COM 641288105 10,839 10,721 9,085.59 105 0.0001
2023-11-07 2023-09-30 13F NEUROPACE COM 641288105 10,839 10,721 0 0.0001
2026-03-30 2023-06-30 13F/A-2 NEUROPACE COM 641288105 118 0 0.00 1 0.0000
2023-09-20 2023-06-30 13F/A-1 NEUROPACE COM 641288105 118 0 0 0.0000
2023-08-03 2023-06-30 13F NEUROPACE COM 641288105 118 0 0 0.0000
2026-03-30 2023-03-31 13F/A-1 NEUROPACE COM 641288105 118 0 0.00 1 0.0000
2023-05-04 2023-03-31 13F NEUROPACE COM 641288105 118 0 0 0.0000
2026-03-30 2022-12-31 13F/A-1 NEUROPACE COM 641288105 118 -3,100 -96.33 0 -100.00 0.0000
2023-02-13 2022-12-31 13F NEUROPACE COM 641288105 118 -3,100 0
2022-11-03 2022-09-30 13F NEUROPACE COM 641288105 3,218 -183 -5.38 12 -29.41 0.0000
2022-08-12 2022-06-30 13F NEUROPACE COM 641288105 3,401 -1,152 -25.30 17 -55.26 0.0000
2022-05-16 2022-03-31 13F NEUROPACE COM 641288105 4,553 4,553 38 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.